Diversities of Podocyte Molecular Changes Induced by Different Antiproteinuria Drugs
Authors:
- 1 May 2006
- journal article
- research article
- Published by Frontiers Media SA in Experimental Biology and Medicine
- Vol. 231 (5) , 585-593
Abstract
Nephrin, podocin, CD2AP, and α-actinin-4 are important podocyte proteins that help maintain the integrity of the slit diaphragm and prevent proteinuria. Studies have shown that angiotensin-converting enzyme inhibitors, glucocorticoids, and all-trans retinoic acid (ATRA) have antiproteinuric effects. However, it is still unclear whether these drugs, with different pharmacological mechanisms, lead to a reduction in proteinuria by changing the expression and distribution of these important podocyte proteins. In this study, changes in the expression and distribution of nephrin, podocin, CD2AP, and α-actinin-4 were dynamically detected in Adriamycin-induced nephrotic (ADR) rats treated with three different drugs: lisinopril, prednisone, and ATRA. Nephropathy was induced by an intravenous injection of Adriamycin. After Adriamycin injection, rats received lisinopril, prednisone, and ATRA treatment, respectively. Renal tissues were collected at Days 3, 7, 14, and 28. The distribution and the expression of messenger RNA and protein of nephrin, podocin, CD2AP, and a-actinin-4 were detected by indirect immunofluorescence, real-time polymerase chain reaction, and Western blotting, respectively. With the intervention of lisinopril, prednisone, and ATRA, changes in the expression of nephrin, podocin, and CD2AP were diverse, which was different from that detected in ADR rats. After lisinopril and prednisone intervention, podocin exhibited prominent earlier changes compared with those of nephrin and CD2AP, whereas CD2AP showed more prominent changes after ATRA intervention. There was no change in the expression of α-actinin-4 molecule. In summary, we conclude that the antiproteinuric effects of lisinopril, prednisone, and ATRA were achieved by changes in the expression and distribution of the important podocyte molecules nephrin, podocin, CD2AP, and α-actinin-4. The pattern in the change of podocyte molecules after lisinopril and prednisone intervention was similar, but the pattern in the change of podocyte molecules after ATRA intervention was different from that of lisinopril or prednisone intervention.Keywords
This publication has 31 references indexed in Scilit:
- Glomerular abundance of nephrin and podocin in experimental nephrotic syndrome: different effects of antiproteinuric therapiesAmerican Journal of Physiology-Renal Physiology, 2005
- ACE inhibitors improve nephrin expression in Zucker rats with glomerulosclerosisKidney International, 2005
- Key molecular events in puromycin aminonucleoside nephrosis ratsPathology International, 2004
- Expression of nephrin, podocin, ?-actinin, and WT1 in children with nephrotic syndromePediatric Nephrology, 2003
- CD2-associated protein directly interacts with the actin cytoskeletonAmerican Journal of Physiology-Renal Physiology, 2002
- Nephrin Redistribution on Podocytes Is a Potential Mechanism for Proteinuria in Patients with Primary Acquired Nephrotic SyndromeThe American Journal of Pathology, 2001
- Congenital Nephrotic Syndrome in Mice Lacking CD2-Associated ProteinScience, 1999
- Subcellular localization of glucocorticoid receptor protein in the human kidney glomerulusKidney International, 1999
- Novel retinoids with receptor selectivity and functional selectivityBritish Journal of Dermatology, 1999
- Positionally Cloned Gene for a Novel Glomerular Protein—Nephrin—Is Mutated in Congenital Nephrotic SyndromeMolecular Cell, 1998